XR 5118
CAS No. 174766-49-5
XR 5118( XR5118 )
Catalog No. M12648 CAS No. 174766-49-5
XR 5118 is a small molecule plasminogen activator inhibitor-1 (PAI-1) inhibitor with IC50 of 3.5 uM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameXR 5118
-
NoteResearch use only, not for human use.
-
Brief DescriptionXR 5118 is a small molecule plasminogen activator inhibitor-1 (PAI-1) inhibitor with IC50 of 3.5 uM.
-
DescriptionXR 5118 is a small molecule plasminogen activator inhibitor-1 (PAI-1) inhibitor with IC50 of 3.5 uM, binds to PAI-1 and reduces plasma PAI-1 activity levels, promotes endogenous thrombolysis and inhibits thrombus accretion; the first nonpeptide compound with significant anti-PAI-1 activity in vivo.Thrombosis Discontinued.
-
In Vitro——
-
In Vivo——
-
SynonymsXR5118
-
PathwayMetabolic Enzyme/Protease
-
TargetPAI-1
-
RecptorPAI-1
-
Research AreaCardiovascular Disease
-
IndicationThrombosis
Chemical Information
-
CAS Number174766-49-5
-
Formula Weight435.985
-
Molecular FormulaC20H22ClN3O2S2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name2,5-Piperazinedione, 3-[[5-[[2-(dimethylamino)ethyl]thio]-2-thienyl]methylene]-6-(phenylmethylene)-, monohydrochloride, (Z,Z)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Friederich PW, et al. Circulation. 1997 Aug 5;96(3):916-21.
2. Einholm AP, et al. Biochem J. 2003 Aug 1;373(Pt 3):723-32.
3. Folkes A, et al. Bioorg Med Chem Lett. 2001 Oct 8;11(19):2589-92.
molnova catalog
related products
-
AZ3976
AZ3976 is an inhibitor of PAI-1 with an IC50 of 16 μM in a plasma clot lysis assay. AZ3976 displays profibrinolytic activities.
-
Aleplasinin
Aleplasinin is a selective and orally active inhibitor of Plasminogen activator inhibitor-1(PAI-1) and a key negative regulator of the fibrinolytic system. Aleplasinin can be used in Alzheimer's disease studies.
-
UK-371804
UK-371804 is a potent and selective inhibitor of urokinase-type plasminogen activator (uPA) with Ki of 10 nM.
Cart
sales@molnova.com